Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New York, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Adenosine Triphosphate (ATP) Assays Global Market Report 2023" -...
-
Zhuhai, China, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Huafa Group is very pleased to announce that the 2023 WTA Elite Trophy Zhuhai, first played in 2015, will return to the Hengqin International Tennis...
-
Wilmington, Delaware, Aug. 16, 2023 (GLOBE NEWSWIRE) -- A mix of regulatory regulations, industry expansion, technical improvements, and a heightened focus on patient safety drives the global...
-
Pune, India, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The global railway signalling system market size was valued at USD 20.23 billion in 2022 and is projected to grow from of USD 21.20 billion in 2023 to...
-
– IMPROVE-ISCHEMIA, a randomized, placebo-controlled trial, with topline data expected in 4Q 2023 – – Additional Phase 2 data read-outs expected in 4Q 2023, including topline from the IMPROVE-HCM...
-
PHOENIX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) - Mesa Airlines, is launching a one of a kind Direct-Entry Captain Referral Program, offering a $20,000 incentive to...
-
New York, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Congestive Heart Failure (CHF) Treatment Devices Market Size & Share Analysis - Growth Trends...
-
ANN ARBOR, Mich., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced two oral presentations to take place in the Late-Breaking Science Session entitled “Clinical trial updates...
-
CALGARY, Alberta, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Birchcliff Energy Ltd. (“Birchcliff” or the “Corporation”) (TSX: BIR) is pleased to announce its Q2 2023 financial and operational results and...
-
IRVINE, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...